Skip to content

Mind Body Intervention for Chronic Lower Back Pain

Mind Body Intervention for Chronic Lower Back Pain: A Pilot Study

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01894282
Enrollment
4
Registered
2013-07-10
Start date
2013-07-31
Completion date
2017-11-30
Last updated
2022-03-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Lower Back Pain

Keywords

Chronic Lower Back Pain, Manual Therapy, Cognitive Behavioral Therapy

Brief summary

This pilot study will evaluate the feasibility of having a non-behavioral health provider deliver a combination of manual therapy (MT) and cognitive behavioral therapy for pain (CBT-p). In addition, we will evaluate differences in outcomes in patients undergoing the combined intervention of CBT-p and MT and those undergoing MT alone.

Detailed description

Given that this is a pilot study we will use simple descriptive statistics for patient characteristics, including age, sex, BMI and baseline scores on outcome measures. In addition we will assess the inter-rater reliability of the scoring of the delivery of the CBT-p by the two trained practitioners utilizing kappa statistics. We will perform data analyses using SPSS.

Interventions

PROCEDUREManual Therapy

Manual Therapy Arm

PROCEDUREMind Body Intervention

Combination of manual therapy and cognitive behavioral therapy for pain.

Sponsors

Canandaigua VA Medical Center
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 69 Years
Healthy volunteers
No

Inclusion criteria

* 18 to 69 years of age with CLBP who are * high risk for poor prognosis based on SBST * currently undergoing chiropractic care.

Exclusion criteria

* Contraindications to either MT or CBT-p. * Patients who are currently undergoing CBT-p * who have been treated for substance abuse in the past year.

Design outcomes

Primary

MeasureTime frameDescription
Visual Analogue ScaleBaseline and 6 weeks post baseline (immediately post intervention)The VAS is a patient completed analogue measure that evaluates pain intensity on a 100 mm long horizontal line, which is anchored at each end with a statement representing the extremes of the dimension being measured. In this case the left hand side reads, no pain and the right hand side reads worst pain possible. The VAS scale utilized will assess pain at the current time. The VAS has been established as a reliable, valid and generalizable measure that can be administered in a wide range of clinical and experimental settings.

Secondary

MeasureTime frameDescription
PROMIS Global Health Scale (GHS)Baseline and 6 weeks post baseline (immediately post intervention)Health outcomes assessment has advanced to a point where generic health-related quality of life (HRQL) measures are often used to examine the health status of populations and the effects of medical interventions. Generic HRQL profile measures, such as the SF-36 Health Survey, provide multiple health domains scores (e.g., physical function, mental health, pain, vitality, etc.), but not an overall index score. Patient reported outcome measurement information system has developed a quality of life tool that provides an overall index score for quality of life. The main advantage of the PROMIS measures over other static health status measures is that the PROMIS domain item banks and scores allow flexibility in administration using either targeted short forms or computerized adaptive testing. This form has recently been validated in comparison to the EuroQual.

Other

MeasureTime frameDescription
Patient Satisfaction QuestionnaireBaseline and post interventionCherkin et al, in the evaluation of a physician education program developed a patient satisfaction questionnaire which was found to be reliable and valid. The questionnaire utilized in this study will incorporate these same questions. Additional questions to be included focus on the burden of the data collection activities, and suggestions for subject recruitment.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026